BP 2006 Annual Report Download - page 120

118
7 Segmental analysis continued
$ million
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2005
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
By geographical area UK
Rest of
Europe USA
Rest of
World
Consolidation
adjustment
and
eliminations Total
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Sales and other operating revenues
Segment sales and other operating revenues 95,375 72,972 101,190 60,314 – 329,851
Less: sales attributable to Innovene operations (2,610) (8,667) (4,309) (686) – (16,272)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Segment revenues from continuing operations 92,765 64,305 96,881 59,628 – 313,579
Less: sales between areas (38,081) (5,013) (2,362) (16,541) – (61,997)
Less: sales by continuing operations to Innovene (5,599) (4,640) (1,508) (43) – (11,790)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Third party sales of continuing operations 49,085 54,652 93,011 43,044 – 239,792
Equity-accounted earnings (8) 18 86 3,447 – 3,543
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Segment revenues 49,077 54,670 93,097 46,491 – 243,335
Segment results
Profit before interest and tax from continuing operations 1,167 5,206 13,139 13,170 – 32,682
Finance costs and other finance expense (80) (268) (366) (47) – (761)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Profit before taxation from continuing operations 1,087 4,938 12,773 13,123 – 31,921
Taxation (289) (1,646) (3,983) (3,555) – (9,473)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Profit for the year from continuing operations 798 3,292 8,790 9,568 – 22,448
Profit (loss) from Innovene operations 234 109 (165) 6 – 184
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Profit for the year 1,032 3,401 8,625 9,574 – 22,632
Assets and liabilities
Segment assets 44,007 26,560 79,838 64,129 (7,832) 206,702
Tax receivable 2 158 6 46 – 212
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Total assets 44,009 26,718 79,844 64,175 (7,832) 206,914
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Includes
Equity-accounted investments 74 1,496 1,420 16,783 – 19,773
Segment liabilities (25,079) (16,824) (33,646) (18,553) 7,832 (86,270)
Current tax payable (798) (1,057) (678) (1,741) – (4,274)
Finance debt (9,706) (433) (6,159) (2,864) – (19,162)
Deferred tax liabilities (2,223) (936) (9,585) (3,699) – (16,443)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Total liabilities (37,806) (19,250) (50,068) (26,857) 7,832 (126,149)
Other segment information
Capital expenditure and acquisitions
Intangible assets 205 43 579 654 – 1,481
Property, plant and equipment 1,340 919 4,804 4,702 – 11,765
Other 53 18 86 746 – 903
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Total 1,598 980 5,469 6,102 – 14,149
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Depreciation, depletion and amortization 2,080 932 3,685 2,074 – 8,771
Exploration expense 32 2 425 225 – 684
Impairment losses 53 7 238 61 – 359
Loss on remeasurement to fair value less costs to sell and on disposal of
Innovene operations 24 273 262 32 – 591
Losses on sale of businesses and fixed assets –37 864 –109
Gains on sale of businesses and fixed assets 107 1,017 282 132 – 1,538